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Abstract 
Analysis involving longitudinal and time-to-event data are quite common in medical 
research. The primary goal of such studies is to simultaneously study the effect of 
treatment on both the longitudinal covariate and survival.  
The early part of the thesis focuses on common model of longitudinal and the survival 
data, it is called joint model. In this joint model, the longitudinal submodel is a 
combination of a random mixed effect model. A semi-parametric submodel is also 
proposed to incorporate the true longitudinal trajectories and other baseline time 
covariates. Moreover, we consider a Bayesian approach which is motivated by the 
complexity of the model. Posterior and prior specification needs to accommodate 
parameter constraints due to the non-negativity of the survival function. 
Bayesian approach was applied to the data using a conjugate and non conjugate prior 
families to obtain parameter estimates. Gibbs sampling is used to find value for estimates 
parameters , , ,  in  the joint model and Metropolis Hasting are used 
to update the Markov chain to estimate parameters , , ,  whose full conditional 
densities cannot be sampled efficiently from the existing methods, leading us to propose 
efficient proposal densities. 
The simulation studies demonstrate that the joint modeling method results in quite 
accurate, efficient and small biases for all the parameters. The analysis of real data 
indicates that when ignoring the association between the longitudinal and the survival 
data would lead to biased estimates for the most important parameters than joint model. 
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CHAPTER ONE 
Introduction  
1.1 Introduction 
In this chapter, we give an overview of the longitudinal studies and some literature 
review of people who have worked in this field,  addition to the objectives of this study. 
Researchers are often interested in the associations between the longitudinal and survival 
data. Often in applied statistics, after some empirical data have been collected, the 
purpose of the analysis is to construct a statistical model. Otherwise; said, we are 
interested in situations where the aim is to explain how an outcome, or response, variable 
of particular interest is related to a set of explanatory variables, or covariates.  
In longitudinal studies in the medical research areas, patients are following over time. In 
this way researchers can make repeated measurements and observe the changes in certain 
markers of a disease and the time to certain clinical events. Hence the resulting data 
consist of both the longitudinal data in the usual sense and the survival (time to event) 
data. Clearly the changes in clinical markers and decline times may not be independent.  
Longitudinal data is data in the form of repeated measurements on the same unit over 
time. Data are routinely collected in this fashion in a broad range of applications, 
including agriculture, life sciences, medical and public health research, and physical 
science and engineering. The main reason and advantage of longitudinal analysis is to 
study the change over time. That is also how longitudinal analysis differs from repeated 
measures analysis. In longitudinal analysis, we model both the dependence of the 
response on the covariates and the associations among responses.
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Longitudinal study has the ability to distinguish the variation in the outcomes across time 
for an individual from the ones among the population. To model the random variability in 
the longitudinal models with continuous outcomes, Diggle, Liang, and Zeger (2002) 
distinguish among three components of variability: random effects, serial association and 
measurement errors.  
In many studies, multivariate outcomes are observed and hence multivariate longitudinal 
models are necessary. Many studies have discrete outcome variables which renders 
traditional likelihood-based methods that require the multivariate normality assumptions 
and cumbersome with time-varying covariates inapplicable. Three modern analyses 
approaches have been developed over the years for the analysis of longitudinal repeated 
measures study with discrete outcome variables. They are the marginal model, the 
nonlinear mixed effect model, and the transition model. Survival analysis examines and 
models the time it takes for events to occur. The event can be death, occurrence of a 
disease, marriage, divorce, etc. The time to event or survival time can be measured in 
days, weeks, years, etc. For example, if the event of interest is heart attack, then the 
survival time can be the time in years until a person develops a heart attack.  Is widely 
used in many fields of studies such as medicine, biology engineering, pharmacology, 
epidemiology, and economics. In medical research, the events could be death, disease or 
failure of treatment. 
Survival analysis focuses on the distribution of survival times and the estimation of the 
relationship between survival and one or more predictors. 
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Joint modeling of longitudinal and survival data can provide more efficient estimates and 
reduce bias in some situations. 
In this research we first contrast the method for modeling the association between aspects 
of a longitudinal process and a time-to-event outcome. A naive approach, where repeated 
measurements are used as time-dependent covariates in a Cox (Cox, D. R., 1972) or 
parametric survival model, is compared to a shared random effects joint modeling 
approach. We then describe how a shared random effects joint model can be fit using 
Bayesian Markov Chan Monte Carlo (MCMC) methods in R software. Such software is 
flexible in allowing a number of possible associations between the longitudinal and time-
to-event processes to be investigated, while predicted survival curves and future 
longitudinal values can easily be obtained for individual using posterior predictive 
distributions. Nevertheless, the Bayesian model implemented in R is currently not 
restricted to models in which the cumulative hazard has a closed form. 
Finally, we apply the models to the primary biliary cirrhosis (PBC) data, which collected 
by the Mayo Clinic from 1974 to 1984, various biomarkers such as bilirubin, 
prothrombin time and albumin were collected longitudinally, our aim was to develop a 
model first to estimate the association between the risk of PBC disease and these 
biomarkers, and second to make predictions about the future rate of  biomarkers and 
probability of PBC disease.
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1.2 Objectives of The Thesis 
  The objectives of research can be summarized as follows:  
1. To solidify the motivation and explanation of the survival regression specification 
of discrete and continuous time models for single event data, to formally examine 
and assess the association between the longitudinal and survival data. 
2. To examine an appropriate form of a longitudinal model for describing the 
behavior of the longitudinal measures over time
3. To investigate and develop the statistical inference procedures based on the 
Bayesian approach, and then to using algorithms that utilize sampling scheme for 
fitting the survival model.
4. In order to illustrate the application of the univariate and multivariate survival 
models a simulation study and real data sets will be presented.
1.3 Structure of The Thesis 
This thesis consists of four chapters. The first chapter is an introductory chapter in which 
definition longitudinal analysis, survival (time to event), joint modeling and Bayesian 
approaches. 
In the second chapter, some background information about the longitudinal analysis is 
presented. Summarizes the common models in survival analysis. At the end of chapter, 
adapted joint modeling for longitudinal and survival data will present.
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In the third chapter, the likelihood of the joint model and the full conditional distributions 
were presented. Also, Bayesian approaches through Markov Chain Monte Carlo Method 
(MCMC) for parameter estimations were considered in the same chapter. 
A comparison study through a simulation study and real data analysis followed by 
conclusion of this study in the final chapter. 
1.4 Literature Review
Methods jointly modeling longitudinal data and survival data have been studied in the 
literature. Tsiatis and Davidian (2004) reviewed the development of joint models, and 
described and contrasted some of earlier proposals for implementation and inference. 
Tseng, Hsieh, and Wang (2005) explored the joint modeling method under the 
accelerated failure time assumption when covariates are assumed to follow a linear mixed 
effects model with measurement errors. Their joint modeling method is based on 
maximizing the joint likelihood with random effects treated as missing data, with a 
Monte Carlo EM algorithm used to estimate all the unknown parameters. In Tseng, 
Hsieh, and Wang (2005), the two models shared unobserved error-free variables. 
Faucett and Thomas (1996) took a Bayesian approach to joint models and developed and 
demonstrated implementation via Markov chain Monte Carlo (MCMC) techniques. Xu 
and Zeger (2001) used joint models as a framework in which to make more efficient 
inference on the marginal (given, say, baseline covariates such as treatment) event-time 
distribution by incorporating the longitudinal data as auxiliary information. Salah (2008) 
took a Bayesian approach to joint longitudinal and time to event with survival fraction.  
6 
 
Chapter Two 
Joint Modeling of Longitudinal and Survival Data 
2.1 Introduction  
In this chapter focuses on modeling the longitudinal and the survival data. When 
association between the two models it is called joint model. In this joint model, the 
longitudinal submodel is a combination of a random mixed effect model and a semi-
parametric submodel is also, a incorporate the true longitudinal trajectories and other 
baseline time covariates. 
Longitudinal studies often produce two types of outcome, namely a set of longitudinal 
response measurements and the time to an event of interest, such as death, development 
of a disease or dropout from the study. Two typical examples of this setting are HIV and 
cancer studies. In HIV studies patients who have been infected are monitored until they 
develop AIDS or die, and they are regularly measured for the condition of the immune 
system using markers such as the CD4 lymphocyte count or the estimated viral load. 
Similarly in cancer studies the event outcome is the death or metastasis and patients also 
provide longitudinal measurements of antibody levels or of other markers of 
carcinogenesis, such as the PSA levels for prostate cancer. 
These two outcomes are often separately analyzed using a mixed effects model for the 
longitudinal outcome and a survival model for the event outcome. However, in mainly 
two settings a joint modeling approach is required. First, when interest is on the event 
outcome and we wish to account for the effect of the longitudinal outcome as a time-
dependent covariate, traditional approaches for analyzing time-to-event data (such as the 
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partial likelihood for the Cox proportional hazards models) are not applicable. In 
particular, standard time-to-event models require that time-dependent covariates are 
external, that is, the value of this covariate at time point t is not affected by the 
occurrence of an event at time point u, with  (Kalbeisch and Prentice 2002, Section 
6.3). However, the type of time-dependent covariates encountered in longitudinal studies 
do not satisfy this condition, due to the fact that they are the output of a stochastic process 
generated by the subject, which is directly related to the failure mechanism. Therefore, in 
order to produce valid inferences a model for the joint distribution of the longitudinal and 
survival outcomes is required instead. The second setting in which joint modeling is 
required is when interest is on the longitudinal outcome. In this case the occurrence of 
events causes dropout since no longitudinal measurements are available at and after the 
event time. When this dropout is nonrandom (i.e., when the probability of dropout 
depends on unobserved longitudinal responses,  simple example concerning the 
occurrence of mastitis in dairy cows, in which the occurrence of mastitis can be modelled 
as a dropout process. It is shown through sensitivity analysis how the conclusions 
concerning the dropout mechanism depend crucially on untestable distributional 
assumptions. This example is exceptional in that from a simple plot of the data two 
outlying observations can be identified that are the source of the apparent evidence for 
non-random dropout and also provide an explanation of the behaviour of the sensitivity 
analysis. It is concluded that a plausible model for the data does not require the 
assumption of non-random dropout), then bias may arise from an analysis that ignores the 
dropout process, see Little and Rubin (2002, Chapter 15). To avoid this problem and 
obtain valid inferences the longitudinal and dropout process must be jointly modeled. 
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One of the modeling frameworks that have been proposed in the missing data literature 
for handling nonrandom dropout is the shared parameter model Follmann and Wu (1995), 
which postulates a mixed effects model for the longitudinal outcome and time-to-dropout 
model for the missingness process. In both settings the joint distribution of the event 
times and the longitudinal measurements is modeled via a set of random effects that are 
assumed to account for the associations between these two outcomes. Excellent 
overviews of this area of biostatistics and statistics research are given by Tsiatis and 
Davidian (2004), and Yu, Law, Taylor, and Sandler (2004).
The joint model describe in this study is very comprehensive and is applicable to a data 
set containing the following information for each   subjects: 
1. Measurements of a continuous time-dependent covariate (or 
disease marker), possibly measured with error at observation times  relative to 
some baseline time (e.g. time of entry the study, or time of infection). 
2. A disease status indicator with  indicating development of disease (time to 
event) and indicating absence of disease at the end of follow up (censored). 
3. Time  from baseline to the onset of disease or total length of follow up if a subject 
is censored.
4. Time fixed or time-dependent measurements   of other variables, such 
as treatment status, age, weight, etc. If it is time fixed  is constant and does 
not depend on . 
The adapted joint model in this study contains two submodels: a covariate tracking model 
(longitudinal model) and a disease risk model (survival model). The longitudinal model 
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relates the measurements  to the true unobserved time-dependent values  Z  
and describes how the true unobserved covariates proves evolves with time and in 
relation to other factors. The survival model relates the risk of disease to the true 
underlying covariate history and other factors.
Before formulating the joint model in detail, we review briefly some basics properties of 
longitudinal and survival models. 
2.2 Longitudinal Data 
Following Henderson et al. (2000) and Wang, Y. and Taylor, J.M.G. (2001), to describe 
the longitudinal model, the response measurements are modeled using a mixed-effects 
model, a popular and flexible choice for continuous longitudinal data. With the notation 
introduced at the beginning of this chapter the adapted model for longitudinal data can be 
written as 
 
 
(2.1) 
Where  denoted the observed value of the marker for subject  at time , 
 a (  vector) denoted the values of  variables 
(other covariates) for subject  at time ,  can be thought of as the true values of 
the marker at time , are error terms assumed to be independent and normally 
distributed with mean zero and variance , that is,  the random intercept 
 assumed to be independent and normally distributed with mean  and variance , 
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that is,   is the fixed slope, and the  vector of unknown parameters 
of dimension ,  represents the effect of the  variables on the marker. 
Longitudinal data is the regression model has the assumption that the errors are normally 
and independently distributed in the population with constant variance. But sometimes, 
one should expect some dependence between the response variables. 
Covariates are often used  as an alternative name for explanatory variables , but perhaps  
more specifically to refer to variables that are not of primary interest in an investigation  
but are measured because it is believed that they are likely to affect the response variable  
and consequently need to be included in analyses and model building. For example age, 
gender, eye color, heir color, and etc. 
2.2.1 Exploring Longitudinal Data 
Longitudinal data are by their very nature complex: there are typically a large number of 
observations on many subjects, and there are often covariates and missing values to 
further confuse the issue. Before wholesale analysis begins, a profitable first step is 
always to explore the data: simple procedures such as plotting or calculating means can 
provide valuable insights into the structure and unusual features of the data.  
In plotting longitudinal data, we seek to address a number of goals: 
 To characterize subject behavior, that is, to observe how the data vary across 
subjects at points in time.  
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 To characterize time behavior, that is, to observe how the response changes with 
time.  
 To characterize covariate behavior, that is, to observe how the response varies 
with one or more covariates. 
 To identify unusual observations in the data.  
 To display all of the data points themselves, for example the primary method of 
plotting is the parallel plot (Weiss & Lazaro, 1992) all the data points are plotted 
with time on the horizontal axis and the response measure on the vertical axis, and 
observations on individual subjects are connected by straight lines. Every subject 
thus appears as a connected sequence of observations on the plot. This allows one 
to observe the individual behaviour of each subject across time, and also to 
observe the variability of subjects within each time point. 
Achieving all or even many of these goals in one plot is a difficult task, the complex 
nature of longitudinal data can often result in a plot which is overly busy with points and 
lines making it difficult to get a feel for the overall features of the data. Despite this, a 
judiciously designed plot or combination of plots can often make sense of complex data. 
When all of the subjects can be assumed to be a sample from some population, valuable 
insight into the average behavior of the population can be achieved by smoothing over 
the subjects and over time in some way. To achieve such a goal, a full account of the 
principles underlying kernel smoothing may be found in Hastie and Tibshirani (1990). 
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2.2.2 Multivariate Longitudinal Data 
In medical studies, it is common to observe multivariate outcomes repeatedly. For 
example, in Community Behavioral Health (CBH) subjects take psychological tests and 
There are 5 test batteries which measure different kind of performance, such as general 
memory, delayed recall, attention, working memory, etc. (Zamrini et al. 2004, Rusinek et 
al. 2004). These test batteries are correlated with each other and therefore multivariate 
analysis for the repeated measurement is necessary. 
Let , be the observed multivariate response 
with q components at time , , are the observation on the  subject 
, and q-dimensional response vector. The model we proposed is a multivariate 
generalization of the model in (2.1) given by: 
 
(2.2)
Where
  are the true values of the multivariate 
response, q-dimensional response vector. 
 is a  
part of the response, and  is a dimension fixed effects vector. 
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 is a  
variation in the response attributable to among-unit sources, and  is a dimension 
  random effects vector. 
 is a vector of measurement errors. 
The assumptions of all variables and parameters in model (2.2) are the same as in (2.1) 
with multivariate instead of univariate.  For more details see Salah, k. A. (2008). 
The challenge of multivariate longitudinal analysis, especially with high-dimensional 
response vector, is to choose a reasonable approximation to the variance covariance 
matrix of  , which takes the form. 
 
Of dimension estimate of longitudinal parameters will be discussed in details in 
the next chapter.
2.3 Survival Data Analysis 
Broadly speaking, survival analysis is a set of statistical methods for examining not only 
event occurrence but also the timing of events. These methods were developed for 
studying death, hence the name survival analysis, and have been used extensively for that 
purpose; however, they have been successfully applied to many different kinds of events, 
across a range of disciplines. Examples include manufacturing or engineering: how long 
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it takes widgets to fail; meteorology: when will the next hurricane be hit the North 
Carolina coast; social: what determines how long a marriage will last; financial: the 
timing of stock market drops, the list goes on. Sometimes other names are used to refer to 
this class of methods, such as event history analysis, or failure time analysis or transition 
analysis, but many of the basic techniques are the same as is the underlying idea, 
understanding the pattern of events in time and what factors are associated with when 
those events occur. 
In order to start with survival analysis, a simple example were considered. A schematic 
depiction of simple survival data for six subjects is shown in Figure 2.1. In this figure, all 
subjects start their survival time at the same point, the study baseline. Further, we assume 
that each person can have the event only once. Three of the six patients (lines ending in 
be death, but it can also be any other endpoint of interest, where we can measure the date 
of onset. In the Figure, there also 3 subjects (#2, 4 and 5) who do not have an event at 
least not while they are in the study. Subject #5 is the only one who completed the entire 
study without having an event. In contrast, two of the cases (open circles, #2 and 4) are 
lost to the study before having an event and before the study follow-up ends; they are said 
to be censored. Actually, #5 is censored also, in this context, censoring simply means that 
-up (whether that was early or at the end of the 
study), he/she had not had the event of interest. Different things can cause censoring, 
depending on the study design. It may be that these study participants decided they did 
not want to continue in the study, and so all we know is that at the time they left the 
15 
 
study, they had not yet had the event of interest. If our event of interest is not death, then 
it may be that censoring is caused by death again, we know that at the time we stopped 
following that person (i.e. when she died), she had not had the event of interest. And as 
noted above, people who have not had the event when all follow-up ends for all subjects, 
are also censored. We can view this as a special type of censoring, because everyone who 
has not had the event or already been censored for some other reason, is censored at this 
time. 
Figure 2.1: Hypothetical survival data for six patients. 
 
As shown in the above example, three main issues were necessary for survival analysis: 
 A beginning event. This needs to be well-defined. 
 A scale or method for measuring time. This could be conventional methods such 
as minutes, days, months, y  
 An ending event. Again, this needs to be well-defined. 
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Missing data is endemic to longitudinal study settings; survival analysis is no exception. 
The various mechanisms for missing data in the survival context are usually grouped 
under the encompassing term, censoring. Most generally, censoring occurs when the 
exact survival time is only known for a portion of the sample, with event times for the 
remaining subjects only known to occur in certain intervals. There are three categories of 
censoring: right, left, and interval censoring.  
In survival analysis, we are interested in the random variable , non negative, defined as 
the time from the starting event to the ending event, for example is that of human life. 
The date of birth is often the beginning event, calendar time is the usual time scale, and 
death is a common ending event. 
In survival time modeling, let  denote the true observed failure time for the  subject 
   denote the censoring time for the  subject,  which is 
taken as the minimum of the true event time  and the censoring time . Furthermore, 
we define the event indicator as   where  is the indicator function that 
takes the value 1 if the condition  is satisfied, and 0 otherwise, that is 
is given by the survival 
function , in literature modeling of survival data usually take the form 
17 
 
(2.3) 
Where 
 (2.4) 
or 
 (2.5) 
where  is a continuous nonnegative random variable (defined on ) representing 
the survival time,   denotes the probability density function PDF of  , and  is 
the cumulative distribution function CDF of  represents the ending event occurs before 
time . 
 is mean the ending event occurs past time . This is the same as saying 
the event time for the  random variable  occurs past This function  is non-
increasing, a monotonic, nonnegative function,  and . 
The hazard function  is defined as the instantaneous probability the ending event 
occurs just past time  given that the event had not yet occurred at . 
 
(2.6) 
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or , the ratio of the probability density function to the survival function   
 (2.7) 
thus, can be written as . 
Hence, from equation (2.7) the survival function can be expressed as 
 
 
(2.8) 
The cumulative hazard function  is the accumulated risk or hazard over time  up to 
time . Defined as 
 
2.4 Censoring and Truncation of Survival Data
A survival time is censored when information on time to outcome event is not available 
for all study participants. Participant is said to be censored when information on time to 
event is not available due to loss to follow-up or non-occurrence of outcome event before 
the trial end. Broadly classifying three types of censoring are encountered: 
a. Right censoring: a subject is right censored if it is known that the event of interest 
occurs some time after the recorded follow-up period. This is noted above in 
Figure 2.1. 
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b. Left censoring: a subject is left censored if it is known that the event of interest 
occurs some time before the recorded follow-up period. For example, you conduct 
a study investigating factors influencing days to first oestrus in dairy cattle. You 
start observing your population (for argument's sake) at 40 days after calving but 
find that several cows in the group have already had an oestrus event. These cows 
are said to be left censored at day 40. This is noted above in Figure 2.1. 
c. Interval censoring: a subject is interval censored if it is known that the event of 
interest occurs between two times, but the exact time of failure is not known. In 
effect we say `I know that the event occurred between date A and date B: I know 
that the event occurred, but I don't know exactly when'. In an observational study 
of Enzootic Bovine Leucosis (EBL) seroconversion you sample a population of 
cows every six months. Cows that are negative on the first test and positive at the 
next are said to have seroconverted. These individuals are said to be interval 
censored with the first sampling date being the lower interval and the second 
sampling date the upper interval. This is noted above in Figure 2.1.  
By contrast, truncated survival time data are those for which there is a systematic 
on survival time itself. We may distinguish two types of truncation: 
a. Right truncation: a subject is right truncated if it leaves the population at risk 
some stage after the study start (and we know that there is no way the event of 
interest could have occurred after this date). For example, in a study investigating 
the date of first foot-and-mouth disease diagnosis on a group of farms, those 
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farms that are preemptively culled as a result of control measures are right 
truncated on the date of culling. 
b. Left truncation: a subject is left truncated if it enters the population at risk some 
stage after the start of the follow-up period. For example, in a study investigating 
the date of first mad cow disease (BSE) diagnosis on a group of farms, those 
farms that are established after the start of the study are said to be left truncated 
(the implication here is that there is no way the farm can experience the event of 
interest before the truncation date).
If no censoring the empirical estimate of the survival function is the proportion of 
individuals with event times greater than . With censoring if there are censored 
observations, then is not a good estimate of the true  so other non-parametric 
methods must be used to account for censoring. 
In the following subsections, some parametric and non-parametric survival models were 
illustrated.
2.5 Non Parametric Survival Models 
2.5.1  Kaplan-Meier Estimator (Product-Limit Estimator )
The Kaplan Meier estimate (Kaplan, E. L. and P. Meier (1958)) of the survival function 
is an empirical or non-parametric method of estimating  from non- or right-censored 
data. It is extremely popular as it requires only very weak assumptions and yet utilizes the 
information content of both fully observed and right-censored data. It comes as standard 
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in most statistical packages (such as R) and can also be calculated by hand. Specifically 
the estimator is given by 
 
Where   is the estimated survival function at time  are the 
ordered survival time, ,  denotes the first observed failure time,  is the 
number of individual at risk at time   and   is the number of individuals who 
experience the event of interest at time  . (individuals censored at time  are included in 
) the resulting estimates form a step function that can be plotted to given a  graphical 
display of survival experience. 
As illustrative example, consider the times of remission (weeks) for 21 leukemia 
patients receiving control treatment:  6+, 6, 6, 6, 7, 9+, 10+, 10, 11+, 13, 16, 17+, 19+, 
20+, 22, 23, 25+, 32+, 32+, 34+, 35+. Note: times with + are right censored. It is useful 
to start the estimation of S(t) by writing the data in ascending order, including the 
censored times in the ranking but ensuring that they are distinguishable from times that 
are not censored. 
Let  is the set of 16 distinct death times observed in the sample and 
,  is the number of deaths at ,  
before the  death time (everyone dead or censored at or after that time), and  is the 
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number of censored observations between the  and  death times. Censorings 
tied at  are included in . 
Two useful formulas are:  (1)   ,      (2)   
Hence, the Kaplan-Meier estimator of the survivorship function (or survival probability) 
summarized in the following table 
Table 2.1 Calculating the KM Estimator 
j      
0 0 0 0 21 1 
1 6 3 1 21   
2 7 1 0 17   
3 9 0 1 16 
4 10 1 1 15   
5 11 0 1 13  0.7529 
6 13 1 0 12  0.6902
7 16 1 0 11 0.6275 
8 17 0 1 10  0.6275 
9 19 0 1 9  0.6275 
10 20 0 1 8 0.6275 
11 22 1 0 7  0.5378 
12 23 1 0 6  0.4482 
13 25 0 1 5 1 0.4482
14 32 0 2 4 1 0.4482 
15 34 0 1 2 1 0.4482 
16 35 0 1 1 1 0.4482 
 
Also, the KM plot for treated leukemia patients is given by 
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2.5.2 Turnbull Estimator 
An estimator of the survival function is available for interval-censored data. In 1976 
Richard Turnbull formulated an expectation maximization algorithm (EM) to estimated 
the nonparametric maximum likelihood estimator (NPMLE) for interval-censored data, 
but 
 The NPMLE for interval-censored data is 
based on  independent, arbitrary interval censored observations . We 
assume that  is interval censored, so that is only known to lie in an interval . 
The derivation of the Turnbull estimator will be introduced here, for example, suppose 
we have 5 failures which occur in a study. The survival times for the 5 patients in this 
hypothetical study are interval censored. The following data set shows the  = 5 interval 
censored data points,   
 .  
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algorithm, equivalence classes 
must be defined to determine at what time points the survival function takes jumps. 
Equivalence classes are defined by each  that is immediately followed by  once the 
endpoints are ordered. In table 2.2 find the equivalence classes, we need to consider all of 
the  intervals, for , and then order the endpoints from smallest 
to largest.  
Table 2.2 Construction of equivalence classes for an interval-censored data set 
Initial Endpoints 1 2 2 5 4 7 3 8 7 9 
Corresponding          
Ordered Endpoints 1 2 2 3 4 5 7 7 8 9
Corresponding           
Labels L L R L L R L R R R 
 
Table 2.2 shows how we obtain the equivalence classes for the hypothetical data set. The 
first two lines in the table are the initial data. The next two lines represent the ordered 
endpoints and their corresponding labels. The fifth line denotes only whether the 
corresponding point is a left L or right R endpoint. Therefore, we have  
equivalence classes which are . Only within these equivalence classes 
can the survival function have jumps. The Turnbull estimator of the CDF is given by
 
 where  is the lower bound of the first equivalence class and  is the upper bound of 
the last equivalence class. The interval  represents the  equivalence class. 
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Therefore,  is undefined for , for , which means that  is 
defined only in between the equivalence classes.  
Before maximizing the likelihood of , the CDF, it is necessary to be familiar with the  
matrix. This is an matrix of indicator variables. As stated earlier, each  
interval represents the censoring interval which contains the failure time for individual  
and  represents the  equivalence class. The  element of the  is defined 
as  
 
The maximum likelihood estimator for the CDF is represented as: 
 
Once the CDF of the survival distribution is obtained, integration techniques can be used 
to calculate the PDF of the survival times, and the survival function in (2.5), 
. As an alternative to maximizing the likelihood for the CDF, we can also maximize 
the equivalent likelihood given as 
 
where  is the  element of the matrix defined earlier, and  represents the jump 
amount within the  equivalence class.  
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The process of maximizing the eq
method of finding the NPMLE. This technique involves finding the expected value of , 
a matrix that has the same dimensions as , and is defined as: 
 
The expected value of is first calculated under an initial  matrix, which is an  
matrix with elements equal to .  is the expected value of  as a function of , and 
is also denoted as . When we treat as an observed quantity, we can estimate the 
proportion of observations in the equivalence class, , as the following: 
The Turnbull method is an example of an Expectation-Maximization (EM) algorithm 
since the final  matrix of jump amounts is found by alternating between the calculation 
of and obtaining an matrix which maximizes . The algorithm stops when the 
difference between successive values for is less than a given tolerance, (see Zhao, 
2008). 
2.6 Semi-Parametric Model (Cox Proportional Hazards Model ) 
This model, proposed by Cox (1972), is perhaps the most-often cited article in survival 
simply referred to as the. Cox model, is its demonstration that one could estimate the 
relationship between the hazard rate and explanatory variables without having to make 
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any assumptions about the shape of the baseline hazard function. Hence the Cox model is 
sometimes referred to as a semi-parametric model. The result derives from innovative use 
of the proportional hazard assumption together with several other insights and 
assumptions, and a partial likelihood (PL) method (a product of conditional likelihoods , 
used in certain situations for estimation and hypothesis testing) of estimation rather than 
maximum likelihood. Here follows an intuitive demonstration of how the model works, 
based on the explanation given by Allison (1984 and 1995). Cox proportional hazard 
regression model is a broadly applicable and the most widely used method of survival 
analysis Cox and Oakes (1984).The model involved is
, 
where  are the explanatory variables of interest and covariates, , 
of -dimension  and the  hazard function. is baseline hazard function, is an 
arbitrary  function of time for any two individuals at any point in time the ratio of hazard 
function is a constant, since when all of them are zero. Because 
the baseline hazard function does not have to be specified explicitly, the procedure is 
essentially a distribution free method. Estimates of the parameters in the model, i.e. 
, are usually obtained by maximum likelihood estimation, and depend only 
on the order in which events occur, not on the exact time of their occurrence. The Cox 
proportional hazard model, instead, leaves the baseline hazard function unspecified. 
The hazard model can be written as 
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Let , then we got 
 (2.9) 
The hazard ratio for two observation  and , where  is 
 (2.10) 
where and are 
independent of time  Cox model is proportional hazard model. 
Remarkably, even though the baseline hazard is unspecified, the Cox model can still be 
estimated by method of partial likelihood Cox (1972). Although the resulting estimates 
are not as efficient as maximum-likelihood estimates for a correctly specified parametric 
hazard regression model, not having to make arbitrary. 
2.7 Parametric Survival Models
Parametric models play an important role in survival analysis, since they offer 
straightforward modeling and analysis techniques. The goal is to estimate the unknown 
parameters to obtain inferences about the scientific problems at hand.  Commonly used 
parametric models include the log normal, negative binomial, gamma, exponential and 
Weibull, which are attractive in their simplicity and the easy interpretability of their 
components. 
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2.7.1 Exponential Model  
In the exponential model, the hazard rate is characterized as: 
(2.11) 
events occur according to a Poisson process). In other words, the risk of an event 
occurring is flat with respect to time. 
Modelling the dependency of the hazard rate on covariates entails constructing a model 
that ensures a non-negative hazard rate (or non-negative expected duration time). One 
way to do this is simply to exponentiate the covariates such that: 
 (2.12) 
Given the way that the hazard rate is specified in the exponential model, the cumulative 
hazard can be written as: 
 (2.13)
Recall from the earlier notes that . As a result, we have: 
 
(2.14) 
This in turn means that the density is: 
 (2.15) 
30 
 
This density means that the duration time T has an exponential distribution with mean 
. In other words, the expected duration in an exponential model is: 
 (2.16) 
Having defined , , and , it is easy to construct the sample likelihood 
for the exponential model:  
 
 
 
 
(2.17) 
 
2.7.2 Weibull Model
The Weibull model the definition density function is 
(2.18) 
The Weibull model is more general and flexible than the exponential model and allows 
for hazard rates that are non-constant but monotonic. It is a two-parameter model ( ¸ and 
), where  is the location parameter and  is the shape parameter because it determines 
whether the hazard is increasing, decreasing, or constant over time. The distribution 
occurs in the analysis of survival data and has the important property that the 
corresponding hazard function can be made to increase with time ( ), decrease with 
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time ( ), or remain constant, by a suitable choice of parameter values. When  
the distribution reduces to the exponential distribution. So the Weibull distribution 
contain the exponential as special case.  
Let , the distribution function can be reformatted to  
 (2.19) 
In the Weibull model, the hazard rate is characterized as: 
 (2.20) 
The survival function for the Weibull is 
(2.21) 
Having defined , , and , it is easy to construct the likelihood for the Weibull 
model:
 
 
 
(2.22) 
In this study Assume the survival time for the subject follows a Weibull distribution  
, where   and , then the 
hazards function in (2.20) becomes 
 (2.23) 
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Where  is the regression coefficient represents the effect of  the marker on the disease  
risk, also,  is the regression coefficient represents the effect of  the other potential  
covariates,  denoted -dimension other potential covariates (time fixed or 
dependent), which  may include some or all of  covariates and  is baseline hazard. 
We assume , over some arbitrary partitioning  of the time   
scale into  intervals, ,  are not necessarily related to this times of the  
marker measurements for all subjects.
2.8 Joint Modeling 
Along with time-to-event data, many  studies also collect longitude. Instead of analyzing 
them separately, joint modeling of longitudinal and survival data has attracted great 
attention in the literature, two approaches have been proposed to carry out the joint 
modeling: a two-stage model (Raboud et al. 1993, Tsiatis et al. 1995, Bycott and Taylor 
1998, Dafni and Tsiatis 1998) and a likelihood based joint model (DeGruttola and Tu 
1994, Faucett and Thomas 1996,Wulfsohn and Tsiatis 1997, Xu and Zeger 2001, Wang 
and Taylor 2001, Salah, k. A. (2008)). It has been shown that by sharing information 
between the longitudinal model and the survival model, the likelihood based approach 
has the advantage of smaller bias and more efficiency in the parameter estimates. While 
applying the joint model to a real data set, we often observe nonlinear trends in the 
longitudinal trajectories and also a large variation in their shapes. Sometime we might 
want to model the survival time and the longitudinal measurement in the mean time, i.e., 
we might want to estimate the  and at the same time, where is a 
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longitudinal measurement which is a certain marker of the study. The final goal of joint 
modeling is to model  .  
Xu and Zeger (2001) use a latent variable model to describe the relationship between 
time-to-event data, longitudinal response, and covariates, in which covariates could only 
affect the response through its influence on an assumed latent process. The model below 
shows the relationship between event time , biomarker response , and treatment 
indicator variable , -dimension, by assuming an underlying latent process  
corresponding to . 
The recent approaches of joint modeling by Xu and Zeger (2001) proposed latent variable 
models where and are modeled simutenously comparing to the two-stage model by 
Tsiatis, 1997.  
 
And  for the survival time 
Where  and  unknown parameter,  is the regression coefficient, and the likelihood  
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Figure 2.2.a The relationship in joint model between  and  
The model is established on the basis of three major assumptions 
a. and  are conditionally independent given a latent process  . 
b.  can affect  either through  or directly. 
c.  can only affect through its influence on . 
To be more specific,  , the observed value of the process at time  is modeled as an 
independent observation from a generalized linear model (GLM) with linear predictor 
. where  is generally assumed to follow a Gaussian stochastic process. And the 
model allows different forms of conditional hazard to be specified for . An 
application of this model is when the auxiliary variable  is an imperfect surrogate end 
point for . 
Another approach to model both survival time and longitudinal marker through latent 
variables was proposed by DeGruttola and Tu (1994). The model is established on the 
basis of three major assumptions 
a. and  are conditionally independent given a latent process and covariate . 
b.  can affect and . 
c. Random effect  can affect  and . 
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The model can be specified as  
 
and 
 
Where  are a -vector of population average regression coefficients, called 
fixed effects, and where  is a -vector of subject-specific regression coefficients, called 
random effect. The matrices  and  are  and  matrices of 
known covariates. Note that and are the numbers of fixed and subject-specific 
regression parameters in the model, respectively. The residual components , are 
assumed to be independent where depends on only through its dimension 
. Hence the likelihood can be written as  
 
Figure 2.2.b The relationship joint model between  and  
Wang and Taylor (2001): include the longitudinal marker as a time-dependent covariate 
in the (proportional hazards) survival model.  
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In this study our joint model composed of two sub models: a covariate  tracking model 
(longitudinal data) and a disease risk model. 
For the longitudinal data we incorporate the model in (2.1). 
 
 
(2.24) 
By incorporating model (2.24) into hazard model in (2.23) we got the joint model of the 
form:  
 
 
(2.25) 
which describes the relationship between survival time and longitudinal data, it assumes 
that, given the true marker value and other covariates. 
The joint model in (2.25) is established on the basis of four major assumptions 
a. and  are conditionally independent given  and covariate . 
b.  can affect and . 
c. can affect and .
d. Unknown parameter  can affect  and . 
The likelihood for the joint model in (2.25),  as 
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Figure 2.3 The relationship  joint model between  and  
2.9 Separate Modeling 
From the joint model in (2.25) 
 
Let  we get the separate model (ignoring  the association between the two sub-
model). 
 (2.26)
Clearly those markers (longitudinal data) and decline time (survival time) are not 
independent. There exist many methods for analyzing such data separately as introduced 
previously. However, joint modeling can provide more efficient estimates and reduce 
bias in many situations (see Xu and Zeger, 2001, and DeGruttola and Tu, 1994). 
a. By using the separate models, when the covariates are measured with error, the 
estimate of the regression coefficient will be attenuated, that is, biased toward 0. 
Joint models can reduce this bias. 
b. When studying the group effect on event time, conditioning on a time-varying 
covariates can mask the group effect. Joint models can overcome this problem. 
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Alternatively we might want to study the group effect on both the longitudinal 
data and the event time. 
c. When censoring is informative about the event of interest, traditional statistical 
methods can give biased estimates of the event time distribution and group effect. 
Joint models may reduce this bias. 
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Chapter Three 
Estimation of Parameters 
3.1   Introduction 
In chapter 2, we have a joint model of longitudinal data and survival data. It contains on 
the unknown parameters we need to estimations, wherefore we consider a Bayesian 
approach which is motivated by the complexity of the model. Posterior and prior 
specification needs to accommodate parameter constraints due to the non-negativity of 
the survival function. 
The two well-known approaches for parameter estimation are maximum likelihood (ML) 
and Bayesian estimation. There exist a number of philosophical differences between the 
two approaches, including whether statistics are treated as the expected outcome from a 
large number of independent trials, usually associated with ML or a measure of 
subjective belief as in the Bayesian framework.   
The fundamental idea behind maximum likelihood estimation is that a good choice for 
the estimate of a parameter of interest is the value of the parameter that makes the 
observed data most likely to have occurred. To do this, we need to establish some sort of 
function that gives us the probability for the data, and we need to find the value of the 
in classical statistics, and it is essentially the product of sampling densities probability 
distributions for each observation in the sample.  
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Bayesian inference is the process of fitting a probability model to a set of data and 
summarizing the result by a probability distribution on the parameters of the model and 
on unobserved quantities such as predictions for new observation Gelman et al.,(1995). 
 
 
(3.1) 
Where the symbol   
Traditional maximum likelihood approach delivers only point estimates and associated 
asymptotic standard error estimates for the model parameters. This motivates the use of 
Bayesian analysis. As the development of computing power and improved scope for 
estimation via iterative sampling methods, Bayesian analysis of data in health, social and 
physical sciences has been greatly facilitated in the last decade. The new estimation 
methods Markov Chain Monte Carlo (MCMC) may be used to augment the data and this 
provides an analogue to the classical expectation maximization (EM) method, (see 
Gelman et al. 1995, 199).
Comparing to maximum likelihood, Bayesian estimations are more natural in parameter 
interpretation and easier to get true parameter densities. In the traditional maximum 
likelihood methods, variance estimates requires asymptotic assumptions which are 
sometimes not available. However in Bayesian framework, variance estimates and other 
posterior summary are produced by Gibbs sampler in the mean time samples of the 
posterior distribution are obtained, (see Chen, Ibrahim, and Sinha, 2004). However 
Bayesian inference has several other advantages over maximum likelihood methods in 
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model building and data analysis flexibilities. In traditional methods, there is no unified 
methodology for comparing non-nested models usually require asymptotic assumptions. 
While for Bayesian inference, model comparison and selections are easily completed via 
Gibbs sampler. Another area that Bayesian paradigm is superior to tradition likelihood 
method is its availability and flexibility of dealing missing values.
Also, unlike maximum likelihood we can consider with high-dimensional variables it is 
not easy to find.
3.2   The Likelihood of  Some Distributions 
Let  be the random variables,  is mean, and  is variance. If 
, then the likelihood of the Normal distribution  
 
 
 
(3.2) 
Where   and  
If ,  is shape parameter and  scale parameter. Then the likelihood of the 
Gamma distribution  
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(3.3) 
Where   and  
If . Then the likelihood of the Inverse Gamma distribution  
 
(3.4) 
Where   and 
3.   Bayesian Estimation 
Our Bayesian method involves a combination of direct sampling from the full conditional 
distribution, Bayesian model includes a suitable prior distribution hat summarizes 
information about  parameter  known or assumed at given time point, prior to obtaining 
further information from empirical data and posterior distribution that summarizes 
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information about a random variable or parameter after having obtained new information 
from empirical data. 
The relationship can be written as 
Where  is posterior distribution,  is prior distribution and  is the likelihood 
of the observed data  given parameter . 
Bayesian inference is then based on Monte Carlo samples drawn from the posterior 
distribution using an Markova Chain Monte Carlo (MCMC) algorithm such as the Gibbs 
sampler. 
The Gibbs sampler, Geman and Geman (1984) is a special case of Metropolis-Hastings 
sampling. Metropolis et al. (1953), Hastings (1970), and the resulting Metropolis 
Hastings (M-H) algorithm, suppose that   is  dimensional 
the complete conditional distributions. 
Conditional distribution are much easier to simulate and usually have simple forms of 
prior distributions. 
An alternative, and more general, updating scheme is as a form of generalized rejection 
sampling, where values are drawn from arbitrary (yet sensibly chosen) distributions and 
'corrected' so that, asymptotically, they behave as  random observations from the target 
44 
 
distribution. This is the motivation for methods such as the Metropolis-Hastings (M-H) 
updating scheme. 
3.3.1   Markov Chain Monte Carlo method (MCMC) 
Markov Chain Monte Carlo (MCMC) is a Monte Carlo method based on sampling from 
Markov Chain processes. 
Monte Carlo integration is the original Monte Carlo approach was initially used to 
generate random number to compute integrals.
 
Where  is a function of  ,  is  probability density function of , defined over 
the interval ,  is observed data, and  is random variable. 
If we draw large number  then we can estimate Monte Carlo integration. 
 
Monte Carlo integration can be used to marginal posterior distribution for a Bayesian 
analysis. 
Estimation of  is  , where 
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The estimated Monte Carlo standard error is given by
 
Markov Chains is a stochastic process, ,  where  takes values in the 
finite set , and is such that 
 
3.3.2   The Metropolis-Hasting Algorithm (M-H) 
One problem with applying Monte Carlo integration is in obtaining samples from some 
complex probability distribution . Suppose our goal is to draw samples from some 
distribution  where , where the normalizing constant K may not be 
known, and very difficult to compute. The Metropolis algorithm generates a sequence of 
draws from this distribution as follows: 
1. Start with any initial value  satisfying . 
2. Using current value, sample a candidate point  from some jumping distribution 
, which is the probability of returning a value of  given a previous value of 
. This distribution is also referred to as the proposal or candidate-generating 
distribution. The only restriction on the jump density in the Metropolis algorithm is 
that it is symmetric, i.e. . 
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3. Given the candidate point , calculate the ratio of the density at the candidate ( ) 
and current ( ) points 
 
4. If the jump increases the density ( ), then accept the candidate point (set 
) and return to step 2. 
5. If the jump decreases the density ( ), then with probability  accept the candidate 
point, else reject it and return to step 2. 
This algorithm generates a Markov chain ( ), as the transition probabilities 
from  to  depends only on  and not ( ). Following a sufficient burn-in 
period (of, say, k steps), the chain approaches its stationary distribution and samples from 
the vector ( ) are samples from P(x). Hasting (1970) generalized the 
Metropolis algorithm by using an arbitrary transition probability function 
, and setting the acceptance probability for a candidate point as 
Assuming that the proposal distribution is symmetric in M-H, recovers the original 
Metropolis algorithm. 
3.3.3   Model Selection  
Bayesian information criterion (BIC)  is a criterion for model selection among a finite set 
of models. It is based, in part, on the likelihood function and it is closely related to the 
Akaike information criterion (AIC). When fitting models, it is possible to increase the 
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likelihood by adding parameters, but doing so may result in over fitting. Both BIC and 
AIC resolve this problem by introducing a penalty term for the number of parameters in 
the model; the penalty term is larger in BIC than in AIC. 
BIC (Schwarz, 1978) and AIC (Akaike, 1987) are an index used in a number of areas as 
an aid to choosing between competing models. It is defined as  
 
(3.5) 
Where  the deviance is function, and is the number of estimated parameters. Deviance 
Information Criterion (DIC) is a hierarchical modeling generalization of the AIC and 
BIC. It is particularly useful in Bayesian model selection problems where the posterior 
distributions of the models have been obtained by Markov chain Monte Carlo (MCMC) 
simulation. Like AIC and BIC it is an asymptotic approximation as the sample size 
becomes large. It is only valid when the posterior distribution is 
approximately multivariate normal. DIC is a goodness of
Spiegelhalter et al. (2002) showed that  and  can be defined as 
 
(3.6) 
Where  is unknown parameter, is the posterior mean 
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(3.7) 
 
 And  is the point estimate of   
 Can be defined as  
(3.9)
Lemma (3.1): 
If , then  
Proof  
 
 
 
 (3.8) 
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3.4   Estimations of Model Specifications 
From the model in (2.24)   
 
Assumed that   and . 
The parameters  , , , and  are the estimators of the unknown parameters  
and respectively.
 Also, from the model in (2.23) 
The parameters  , , and  are the estimators of the unknown parameters  and  
respectively. 
Faucett et. al. (1996), has successfully adopted the Bayesian approach to study the same 
model as Wulfsohn. We will use this approach in our modeling, focusing on the 
estimation of  the joint posterior density of all unknown model parameters  
. 
The joint posterior density of the parameters depends on their prior density and likelihood 
assumptions. We use  to denote marginal and to denote conditional densities. 
 
50 
 
For the likelihood function, we assume 
 The data from different subjects are independent.
 For each subject , given all the unknown parameters in  and covariates , 
the longitudinal data is independent of the survival time.
 For each subject , given ,  are independent and 
 has normal distribution . 
Thus, the contribution of subject  to the conditional likelihood is used by Salah, (2008) 
 
 
where . 
For subject , the survival probability at his survival time , using model (2.8) is then 
given by 
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And using model (2.23) we get 
 
 
 
 
 
 
 
 
 
 
 
 
 
(3.10) 
Where ; for , ,  and  
 are all the grid points in interval  for subject ;  
 are all the grid points in interval for subject ;  and  
. 
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3.5   Full Conditional Distribution 
The Bayesian framework computes the probability of a parameter given the data, 
posterior distribution . For any component  of , the full conditional density of 
 given remaining parameters  is proportional to the posterior density of  with the 
remaining  parameters treated as fixed. That is, . 
Based on the joint posterior distribution of the parameters in section 3.4, both Faucett and 
Thompson (1996) and Wang and Taylor (2001) derive the full conditionals, but we prefer 
 The full  
conditional distributions of the parameters appearing only in the longitudinal model can 
be derived as follows.  
 The variance of the measurement error by posterior distribution  
  
 
 
 
 
 
 
(3.11) 
Where   and    
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 The intercept variance  
Where   
The intercept mean 
 
 
 
 
 
(3.13) 
Where   
 
 
 
 
 
 
(3.12) 
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 The random intercept  , for  
Where     and     
 The average rate of decline of the marker  
 
(3.15) 
 
Here      and    
 
 
 
 
 
 
(3.14)
55 
 
 The effect of the variables on the marker ,  
 
Where 
and
 
 and  the remaining covariates after   
covariate  is excluded from .  
 
 
(3.16)
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 The baseline hazard 
 
 
 
(3.17) 
Where 
 
and  is the number of event occurring in time interval .  
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 The regression coefficient of the effect of the marker on the risk  
 
 
 The regression coefficient of the effect of the other potential covariates  
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We do not have the form of a standard distribution for parameters  since their full 
conditional density have no conjugate prior.  For each of these parameters, we propose 
using probability density function as normal  proposal density. 
We note that the full conditional distributions of the parameters , , ,  
in our joint model are a product of its prior density and some standard distribution which 
are conjugate priors for these parameters. 
While the conditional distribution of the parameters , , if the contributions from the 
survival data are ignored, then the normal distribution are conjugate priors. 
The main difficulty which we will meet in the prior distributions is that when no standard 
form appears in the posterior distribution. In general, we do not have performance in 
choosing priors for the parameters ,  since their full conditional densities have no 
conjugate priors. One may use normal priors for , since they take values belong to the 
real line.   
We can see no prior information about the unknown parameter, we can consider using 
diffuse priors. A diffuse prior plays a minimal role in the posterior distribution and often 
has no finite mean or finite variance the most often used diffuse priors are improper 
priors whose density has no finite integral. One of the most often used improper priors for 
,  and  has density (improper)  which corresponds to  or 
. This improper prior assumes that log-transformation of the parameters is uniform 
over the real line. For the , the most natural and popular improper prior is 
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uniform over the real line, which corresponds to a  (see Gelman et al., 1995, and  
Salah, 2008). 
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Chapter Four 
Applications
In this chapter, the aim is to evaluate the performance of the joint model simulation 
studies to apply in R language. We investigate how well the parameters in our joint 
model can be estimated of effects, bias and coverage rate. Moreover, we evaluate the 
performance of the joint model and separate model in real data,  we apply the models to 
the primary biliary cirrhosis (PBC) data, which collected by the Mayo Clinic from 1974 
to 1984, our aim was to develop a model first to estimate the association between the risk 
of PBC disease and these biomarkers, and second to make predictions about the future 
rate of  biomarkers and probability of PBC disease, finally, we compare these results 
between the joint and separate modeling approach.  
4.1  Simulated Data  
4.1.1  Generation of The Data 
We setup our simulation study by samples of size  subjects are randomized. 
Each longitudinal marker in model (2.24), , ; , was 
simulated as the sum of  the trajectory function  and the error terms , each 
subject has his observed longitudinal measured  at time points 
, until the relapse or reaches the end of the study. 
For the survival data, we consider a model in (2.23) to be for , where   is binary 
baseline covariates with half of the subjects having one and the other half having  zero. 
We took the mean of the Poisson process at time  as in (2.23) to be for . 
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Estimated to get an initial estimate of the parameters , say 
 and use them as initial values in MCMC sampler. 
4.1.2 Summary Statistics  
Salah, (2008,p111); used  be ageneric notation for whatever parameter we are 
considering and its true value (with which we generate the data sets) be . Let , 
 and  be its point estimate,  quantile estimate,    
quantile estimate, and standard error estimate, respectively, obtained from analyzing the 
 data set. The Estimate, Monte Carlo Standard Deviation (MCSD), Mean Squared 
Error (MSE), 95% Confidence Coverage Rate (CCR), and Bias in Percentage Terms 
(BPT) are calculated as follows:   
 
 
(4.1)
                                       
 
(4.2) 
                   
 
(4.3) 
 
(4.4) 
 
 
(4.5) 
                         
 
(4.6) 
 
With Bayesian approach, ,  and  are the posterior median, 
the posterior quantile, the posterior  quantile, and posterior variance of , 
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respectively, estimated as the sample median, the sample quantile, the sample 
 quantile, and the sample variance, respectively, of a single series of SCMH 
sampler for . By doing so, we  have used frequency evaluations of Bayesian inferences. 
According to Gelman et al. (1995,p104), frequency evaluations of Bayesian inferences 
hinge on the fact that if  the true data distribution is included in the class of models, so 
that  for some , and under some regularity conditions, then in repeated  
sampling with fixed , the posterior mode, mean, and median are asymptotically 
unbiased and efficient estimates for , and the mode is approximately normally 
distribution for large sample sizes. Our primary simulation study shows that the estimates 
based on the sample mean and the coverage rates of (4.5) are almost the same as the 
estimates based on the sample median and the coverage rates of (4.6), respectively, for all 
parameters. Our estimation results for the other parameters are based on the sample mean 
and the coverage rate of (4.5). 
We use 100 data replications, thus the resulting estimates are subject to sampling 
variation (Monte Carlo Error). This variation for the point estimate can be calculated as  
(4.7)
For the approximate  coverage rate   the Monte Carlo error is 
 
 
(4.8) 
Are almost the same as the estimates based on the sample median and the coverage rates. 
For the model (2.24), we fit a mixed model of the form   
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For the model (2.23), we use a Cox proportional hazards model and maximize the partial 
likelihood function. 
4.1.3 Choosing Prior Distributions  
We consider marginal uninformative prior by choosing uninformative prior for each 
parameter when assuming other parameters are known, and then using the product of 
these individual uninformative prior as our find prior. This approach leads to use of flat 
prior for , b, , ,  and use of  for ,  for   and of  for . 
With these prior, the corresponding full conditional distribution in chapter (3), making 
sampling based on these full conditional distribution straightforward, see Box &Tiao 
(1973).
In general, one should be cautious when using improper priors since this may lead to 
improper posterior distributions. As mentioned above, improper priors are assigned to 
variance parameters  and baseline hazard parameters .To ensure that the 
posterior densities for all parameter are proper and have finite mean and variance, we can  
consider our priors for the parameters , b, , , and   to be , for ,  
and  to be  .
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4.1.4  Sampling Based on Full Conditional Densities 
In this study, we discuss some issues related to implementing the SCMH sampler 
algorithm for our joint modeling approach. Throughout this study, the true values of the 
parameters, which are used to generate the  data sets, are in table 4.1.  
Sampling for parameters ,  and  is straight forward since their full conditional 
densities are of standard forms in model (3.11), (3.12), (3.13). For the parameters whose 
full conditional densities do not have a standard form, we use a Metropolis-Hastings (M-
H) step to update the iterations of SCMH sampler. This method might cause slow 
convergence of the SCMH sampler if the proposal densities in the (M-H) step are not 
close to the target densities and hence the iterations do jump infrequently or jump with 
tiny steps. Therefore, we will use the full conditional density as a proposal density in 
Gibbs sampler algorithm, and in sampling process each updating step for these 
parameters, a new draw from the full conditional density is always accepted. 
For the parameter in the longitudinal model , , and  cannot draw a random variate 
from these densities directly due to the terms from the survival data. We use the 
Metropolis-Hastings (M-H) algorithm to obtain the update in the Gibbs sampling 
sequence. We use the full conditional densities, which are obtained from the longitudinal 
model by ignoring the survival data, as the proposal densities (3.14), (3.15), and (3.16). 
These proposal densities are all normal and so sampling from them is simple. These 
proposal densities appear to be good choices since with or without the survival data, the 
behavior of the parameters appearing in the longitudinal model should remain relatively 
unchanged. 
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For the survival parameter  and  have no standard distribution, it is just an algebraic 
expression which come from the contribution of the longitudinal and survival data so 
that, for such parameters, one cannot draw random variates from their full conditional 
densities. For each of these parameters we propose using a normal density as a proposal 
density, and then using SCMH.     
4.1.5 Simulation Results 
All the parameters were assumed independent a prior and assigned non-informative prior. 
So, we specify for each parameter a reasonable and fast method to obtain an initial value 
(using the {lm} function in R, see Appendix 1). Estimates of parameters are based on a 
subsequent chain of 5,000 iterations. More iterations would of course be preferable, but 
limited computing power made these calculations very time-consuming.
The Gibbs sampler was run 5000 iterations after 1000 burn-in. The histogram, the time series 
plots of one sequence of Gibbs samples for different number of iterations and the average 
number of these iterations for all the parameter are presented in Figures 4.1.a. Visual 
inspection suggested that convergence was fairly rapid; as shown in these Figures.
Table 4.1 shows the true and estimated values of the model parameters from a simulation 
study. Moreover, MCSD, Mean Square Error, Bias as percent of true parameter, MCE, 
and 95% highest posterior density intervals for each parameter in the joint model, are 
represented in the same table. Parameter estimations in the joint modeling results have 
small standard errors for all parameters; the mean parameters are very mild and close to 
the true values. The small biases of the estimates are due to Monte Carlo simulation error. 
For the parameters in the longitudinal model, the estimates are less biased since they have 
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a closed distribution form as mentioned above. Due to including the survival information, 
the joint model produces slightly less biased estimates for mean intercept  and  slope 
. The estimates of all the parameters from the joint modeling analysis are quite 
accurate and efficient. 
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4.2 Real Data 
4.2.1 Application to Real Data Set 
As an illustrative application of joint modeling we consider the primary biliary cirrhosis  
(PBC) data collected by the Mayo Clinic from 1974 to 1984 [14]. PBC is a rare but fatal 
chronic liver disease of unknown cause characterized by inflammatory destruction of the 
small bile ducts within the liver, which eventually leads to cirrhosis of the liver. 
Various biomarkers such as bilirubin, prothrombin time and albumin were collected 
longitudinally, and interest is on examining whether these biomarkers relate to the natural 
history of disease. In this study 312 patients are considered of whom 158 were randomly 
assigned to receive D-penicillamine whereas the other 154 were randomly assigned to the 
placebo group. Baseline covariates, for example age and gender, were measured at entry 
time of the study. Multiple repeated laboratory results from irregular follow-up visits are 
also available in this dataset. The original clinic protocol had specified visits at 6 months, 
1 ye
worsening medical condition. The number of visits ranges from 1 to 16, and the median 
number of repeated measurements is 5. The median interval between visits is 
approximately 1 year. By the end of the study, 140 out of the 312 patients had died and 
the observed event time ranges from 41 to 5225 days.
In the original Mayo model, the prediction model for survival is based on age, total serum 
bilirubin value, serum albumin value, prothrombin time, and the presence or absence of 
edema and diuretic therapy. For simplicity, our joint model will only consider the 
repeated measurements of total serum bilirubin value as our longitudinal covariates, and 
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age, gender and treatment group as our survival covariates. Based on the clinical 
literature, we performed a logarithmic transformation of serum bilirubin to be used for 
our analysis and death is defined as our event of interest. 
We are interested in testing for a treatment effect on survival after adjusting for the 
longitudinal bilirubin levels. Due to the right skewness of the observed serum bilirubin 
level, we will work with the natural logarithm of serum bilirubin for the remainder of this 
analysis.
As a descriptive analysis the Kaplan-Meier estimate for the time to death and the subject-
specific longitudinal profiles for the two treatment groups are depicted in Figures 4.1.b 
and 4.1.c. We observe that in both groups patients show similar variability in their 
longitudinal profiles, whereas from the Kaplan-Meier estimate in Figure 4.1.b it seems 
that the DPCA group has slightly higher survival than the placebo group after the 
fourteen months of follow-up. 
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Figure 4.1.b (PBC data) The Kaplan-Meier estimate of the survival function for the 
two treatment groups.
 
Figure 4.1.c (PBC data) The log longitudinal data for the two treatment groups. 
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4.2.2 The Joint Model 
For our joint model on the PBC dataset, we need to specify a growth curve model and a 
survival model. Similarly, we will use a linear mixed model with a fixed slope and 
random intercept for our trajectory function:  
 
 
 
 
And  
 (4.9) 
Where   are the repeated log serum bilirubin measurements, and the random 
intercept and random error are approximated by a normal distribution. The mean and the 
variance of the random intercept,  and  are unknown and has to be estimated too.  
Consequently, our hazard function for the joint model will be:  
 
(4.10) 
where is the regression parameter for the log serum bilirubin trajectory and 
  are the regression parameters for the survival covariates age, gender 
and treatment. For simplicity, we assumed that the baseline hazard is a constant. When 
 in model (4.10) then we got separate model. 
Table 4.2 shows the result of the joint modeling approach on the DPCA subset of the 
PBC data. In addition to that, we also performed separate survival model analyses using 
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available measurement of log serum bilirubin that is taken closest to the time of the event. 
The purpose of the separate model analyses is to illustrate how the application of our 
methodology serves our motivation of modeling the longitudinal outcome that occurs at 
the specific event time in order to have a more accurate representation of its effect on 
survival. Besides this measurement, covariates age, gender and treatment are also 
 
A comparison between the separate model  with the joint model reveals some interesting 
features. In particular, we observe that the regression coefficient for drug variable is 
larger in magnitude in the joint model, which results in a slightly stronger treatment 
effect. Much stronger bias is observed for the effect of the DPCA, with estimated 
regression coefficient  for separate model and  for the 
joint model, which indicates that the DPCA  measurements effected the survival under 
the joint model more than in the separate model. 
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Table 4.2 Parameter estimates from joint and separate modeling approaches 
Parameter 
Joint Model Separate Model 
Estimate Std. 
Error. 
P-Value Estimate Std. 
Error. 
P-Value 
 0.729 0.036 <0.001 -- -- -- 
 0.914 0.022 <0.001 -- -- -- 
 0.116 0.005 <0.001 -- -- -- 
 1.2558 0.0809 <0.0001  1.06275 0.08437 0.0000 
 2.0228 0.0693 <0.0001 1.36192 0.38189 0.0012 
 -0.0965 0.2086 0.6438 -0.09331 0.21343 0.6621 
 -0.1578 0.1238 0.3241 -0.10186 0.15871 0.5210 
 0.519 0.021 <0.001 -- -- -- 
Model fit
AIC BIC Log.Lik AIC BIC Log.Lik 
5068.88 5106.31 -2524.44 3074.721 3108.153 -1531.36 
5068.88 5106.31 -2524.44 3074.721 3108.153 -1531.36
As an alternative to the Wald test, a likelihood ratio test (LRT) and AIC can be also used 
to test for a longitudinal effect. To perform this test we need to fit the joint model under 
the null hypothesis of no longitudinal effect in the survival sub model. The results are 
shown in Table 4.3. 
Table 4.3 Model selection criteria 
Model AIC BIC log.Lik LRT df p.value 
Joint 4049.54 4113.17 -2017.77 
0.15 1 0.00697 
Separate 4071.39 4138.76 -2017.69 
It is clear that the joint model fit the data better than the separate model since 
 is smaller than the  . Moreover, the  p-value indicates 
that there is significant deference between the two models due to longitudinal data. 
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4.3 Summary and Conclusions 
Joint modeling of longitudinal and time-to-event data is one of the most rapidly evolving 
areas of current biostatistics research, with several extensions of the standard joint model 
presented here already proposed in the literature. These include, among others, handling 
multiple failure types, considering categorical longitudinal outcomes, assuming that 
several longitudinal outcomes affect the time-to-event, and associating the two outcomes 
via latent classes instead of random effects.
Furthermore, one very promising subfield which has emerged within the general joint 
modelling framework, is the use of these models in personalized medicine. In particular, 
there is lately a great need for tools that can help physicians take better informed 
decisions regarding their actions for the specific patients that they treat and not for an 
such a flexible 
dynamic tool, is the use of random effects and their time-dependent nature. For instance, 
as longitudinal information is collected for patients, we can continuously update the 
predictions of their survival probabilities, and therefore be able to discern between 
patients with low and high risk for an event. 
One of the main practical limitations for joint modeling in finding its way into the 
toolbox of modern statisticians was the lack of free and reliable software. The R package 
JM (it can be downloaded from the CRAN website http://cran.r-project.org/) has been 
developed to fill this gap to some extent. JM has a user-friendly interface to fit joint 
models and also provides several supporting functions that extract or calculate various 
77 
 
quantities based on the fitted model (e.g., residuals, fitted values, empirical Bayes 
estimates, various plots, and others). 
From the simulation results, we find that the joint model  method usually has the smallest 
biases, quite accurate and efficient, and the largest coverage rates close to the nominal 
level (95%), joint model method produces less biased estimates and more reliable 
standard errors. Parameters , , , ,  and  estimations in the joint modeling 
results 3.952, 5.89 , -3.94, -0.346, 0.123, and 18.7 respectively are very mild 
and close to the true values. The biases of the estimates 1.2%, 2.5%, 1.15%, 1.09%, -2.8%,
and -4.3% respectively are small due to Monte Carlo simulation error. Also, we have 
small standard errors for all parameters. For the parameters in the longitudinal model, the 
estimates are less biased since they have a closed distribution form as mentioned above. 
Due to including the survival information, the joint model produces slightly less biased 
estimates for mean intercept and  slope .  
From the real data results, we see that the regression coefficient for drug variable was
larger in magnitude in the joint model, which results in a slightly stronger treatment 
effect. Much stronger bias is observed for the effect of the DPCA, with estimated 
regression coefficient ( =1.06275) for separate model and ( 1.2558) for the joint 
model, which indicates that the DPCA  measurements effected the survival under the 
joint model more than in the separate model. Compared to the joint model, the separate 
analysis produces relatively large bias in most model parameters, also the joint model in 
general produces more accurate point estimates than the separate analysis. Comparisons 
of the mean square errors and AIC between the two approaches (  is 
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smaller than the  ) again suggest that the joint model performs 
superior to the separate analysis.  
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APPENDIX A 
This is data generating function for simulation (chapter 4)  
#This appendix gives R code for generating observations from the joint model. These 
observations can be used in simulation study 
#to study the properties of the estimators (Run these codes just once).
# The following packes were needed to run these codes and later codes 
#1. "mcmc"  2.  "JM"  3. "lcmm"  4. "actuar"    
  
############################################################################# 
###########    Program One           ##################### 
###########Generate Observed and Initial values for all parameters ##################### 
############################################################################# 
y <- numeric() #measurement vector
id <- numeric() #subject id vector 
ni <- numeric() #number of measurements for each subject 
t <- numeric() #measurement time vector 
u <- numeric() #uniform for CDF method
censor <- numeric() # vector of censoring times 
m <- 100 # number of subjects 
a <- numeric() # random intercepts vector
b <- numeric() #random slopes vector 
mualpha <- 4; mubeta <- -4; sigmaa <- 1; sigmab <- 1; sigmae <- 0.01 
k <- 1 # dummy variable
g <- -2 # gamma 
c <- 0.00005 #baseline hazard 
d <- numeric() #failure time vector 
end <- numeric() # combined event time vector 
f <- 0
### generate slopes, intercepts, event times, id vector 
f <- 0 
for(i in 1:m){ 
u[i] <- runif(1,0,1) 
a[i] <- rnorm(1,mualpha,sqrt(sigmaa)) #create intercepts 
b[i] <- rnorm(1,mubeta, sqrt(sigmab)) # create slopes
#create event times by CDF method 
d[i] <- (log(1-g*b[i]*log(1-u[i])/(c*exp(g*a[i])))/(b[i]*g)) 
censor[i] <- rexp(1,0.01) #create censoring times
if(d[i]>censor[i]) f <- f+1 
end[i] <- min(d[i],censor[i]) #combined event time 
# determines number of measurements per subject
ni[i] <- rpois(1,10) 
for(j in k:(k+ni[i]-1)){
id[j] <- i} 
k <- k+ni[i]} 
r <- 0 
k <- 1 
# create measurement vectors 
for(i in 1:sum(ni)){ 
if(i>1){ 
if((id[i]-id[i-1])==1) {r <- 0 
k <- k+1}} 
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t[i] <- rexp(1,10)+r 
r <- t[i] 
y[i] <- rnorm(1,a[k]+b[k]*t[i],sqrt(sigmae))} 
# create censoring indicator vector 
s <- numeric() 
for(i in 1:m){ 
  s[i] <- 0  
  if(end[i]==d[i]) s[i] <- 1} 
d <- end 
 
 
#We specify for each parameter a reasonable and fast method to obtain an initial value. 
 
#The random slopes and intercepts alpha and beta 
 
alphas <- numeric() 
betas <- numeric()
for(i in 1:m){ 
alphas[i] <- lm(y[id==i]~t[id==i])$coefficients[1] 
betas[i] <- lm(y[id==i]~t[id==i])$coefficients[2] } 
 
#The means and variances of  mu-alpha, mu-beta, segmas-alpha, segmas-beta 
mualpha <- mean(alphas)
mubeta <- mean(betas) 
sigmaa <- var(alphas) 
sigmab <- var(betas) 
 
#The variance of the measurement error semas-e 
sigmae <- mean((y-(alphas[id]+betas[id]*t))^2)
 
#The regression coeffecient gamma 
test1 <- list(a=alphas,b=betas,death=d,censor=s)
q <- coxph(Surv(death,censor)~a+b,data=test1)
gamma <- mean(q$coef[1],q$coef[2])
 
#The baseline hazard c 
a <- 0 
for(i in 1:m){ 
a <- a+exp(gamma*alphas[i])*(exp(gamma*betas[i]*d[i])-1)/gamma/betas[i]}
c <- rgamma(1,sum(s),a)
 
############################################################################# 
###########    Program Two           ##################### 
###########  Generate Survival Data            ##################### 
############################################################################# 
y <- numeric() #measurement vector
id <- numeric() #subject id vector 
ni <- numeric() #number of measurements for each subject 
t <- numeric() #measurement time vector 
u <- numeric() #uniform for CDF method 
censor <- numeric() # vector of censoring times 
m <- 100 # number of subjects 
a <- numeric() # random intercepts vector
b <- numeric() #random slopes vector 
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mualpha <- 4; mubeta <- -4; sigmaa <- 1; sigmab <- 1; sigmae <- 0.01 
k <- 1 # dummy variable 
g <- -2 # gamma 
c <- 0.00005 #baseline hazard 
d <- numeric() #failure time vector 
end <- numeric() # combined event time vector 
f <- 0 
### generate slopes, intercepts, event times, id vector 
f <- 0 
for(i in 1:m){ 
u[i] <- runif(1,0,1) 
a[i] <- rnorm(1,mualpha,sqrt(sigmaa)) #create intercepts 
b[i] <- rnorm(1,mubeta, sqrt(sigmab)) # create slopes 
#create event times by CDF method 
d[i] <- (log(1-g*b[i]*log(1-u[i])/(c*exp(g*a[i])))/(b[i]*g)) 
censor[i] <- rexp(1,0.01) #create censoring times
if(d[i]>censor[i]) f <- f+1
end[i] <- min(d[i],censor[i]) #combined event time 
# determines number of measurements per subject 
ni[i] <- rpois(1,10) 
for(j in k:(k+ni[i]-1)){
id[j] <- i} 
k <- k+ni[i]}
r <- 0 
k <- 1 
# create measurement vectors 
for(i in 1:sum(ni)){ 
if(i>1){ 
if((id[i]-id[i-1])==1) {r <- 0
k <- k+1}} 
t[i] <- rexp(1,10)+r 
r <- t[i] 
y[i] <- rnorm(1,a[k]+b[k]*t[i],sqrt(sigmae))} 
# create censoring indicator vector
s <- numeric() 
for(i in 1:m){ 
  s[i] <- 0  
  if(end[i]==d[i]) s[i] <- 1} 
d <- end 
 
############################################################################# 
###########    Program Three           ##################### 
###########  Main Program for Simulation          ##################### 
############################################################################# 
#We create a matrix in which to store the values of the parameters at each 
#iteration, and then begin the loop in which the parameters will be updated. 
#K represents the total number of iterations, and burn represents the number 
#of iterations to discard in order to ensure convergence. 
 
K <- 5000; burn <- 1000; m <- 100; alphasm <- numeric(K) 
storage <- matrix(NA, K, 8) 
for(j in 1:K) 
{ 
 #Updating the model parameters 
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 for (i in 1:m) 
 { 
  alphaprop <- rnorm(1,alphas[i],0.1) 
  a <- -c*exp(gamma*alphas[i])*(exp(gamma*betas[i]*d[i])-1)/gamma/betas[i] 
  b <- -c*exp(gamma*alphaprop)*(exp(gamma*betas[i]*d[i])-1)/gamma/betas[i] 
  q <- -(alphas[i]-mualpha)^2/2/sigmaa 
  e <- -sum((y[id==i]-(alphas[i]+betas[i]*t[id==i]))^2/2/sigmae)-(alphas[i]-
mualpha)^2/2/sigmaa 
  f <- -sum((y[id==i]-(alphaprop+betas[i]*t[id==i]))^2/2/sigmae) -(alphaprop-
mualpha)^2/2/sigmaa 
  qr <- -(alphaprop-mualpha)^2/2/sigmaa 
  U <- runif(1,0,1) 
  if(log(U)<b+f+qr+gamma*s[i]*(alphaprop-alphas[i])-a-e-q) 
  alphas[i] <- alphaprop  
 } 
 #Note that we take the logarithm of the ratio in order to avoid exponentiating, 
#thus improving numerical stability.
 
 #The random slopes
 for (i in 1:m) 
 { 
  betaprop <- rnorm(1,betas[i],0.1) 
a <- -c*exp(gamma*alphas[i])*(exp(gamma*betas[i]*d[i])-1)/gamma/betas[i]
  b <- -c*exp(gamma*alphas[i])*(exp(gamma*betaprop*d[i])-1)/gamma/betaprop 
  q <- -(betas[i]-mubeta)^2/2/sigmab
  e <- -sum((y[id==i]-(alphas[i]+betas[i]*t[id==i]))^2/2/sigmae)-(betas[i]-
mubeta)^2/2/sigmab 
  f <- -sum((y[id==i]-(alphas[i]+betaprop*t[id==i]))^2/2/sigmae)-(betaprop-
mubeta)^2/2/sigmab
  qr <- -(betaprop-mubeta)^2/2/sigmab 
  U <- runif(1,0,1) 
  if(log(U)<b+f+qr+gamma*s[i]*d[i]*(betaprop-betas[i])-a-e-q)
  betas[i] <- betaprop  
}
 # The marker means and variances  
 mualpha <- rnorm(1,mean(alphas),sqrt(sigmaa/m))
 mubeta <- rnorm(1,mean(betas),sqrt(sigmab/m)) 
 sigmaa <- rinvgamma(1,m/2-1,sum((alphas-mualpha)^2)/2) 
 sigmab <- rinvgamma(1,m/2-1,sum((betas-mubeta)^2)/2) 
#The regression parameter
 gammaprop <- rnorm(1,gamma,0.01) 
 a <- numeric() 
 b <- numeric() 
 for(i in 1:m) 
 { 
  a[i] <- -c*exp(gamma*alphas[i])*(exp(gamma*betas[i]*d[i])-1)/gamma/betas[i] 
  b[i] <- -c*exp(gammaprop*alphas[i])*(exp(gammaprop*betas[i]*d[i])-
1)/gammaprop/betas[i] 
 } 
 U <- runif(1,0,1) 
 if(log(U)<(gammaprop-gamma)*sum(s*(alphas+betas*d))+sum(b)-sum(a)) 
 { 
  gamma <- gammaprop
 } 
 #The baseline hazard c 
 a <- 0 
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 for(i in 1:m) 
 { 
  a <- a+exp(gamma*alphas[i])*(exp(gamma*betas[i]*d[i])-1)/gamma/betas[i] 
 } 
 c <- rgamma(1,sum(s),a) 
 
 #The measurement error 
 expect <- function(alphas,beta,t,id)  
 { 
  k <- numeric() 
  for(i in 1:length(y)) 
  { 
   k[i] <- alphas[id[i]]+betas[id[i]]*t[i]  
  } 
  k 
 } 
sigmae <- rinvgamma(1,length(y)/2-1, sum((y-expect(alphas,betas,t,id))^2)/2)
  
 storage[j, ] <- c(j, mualpha, mubeta, sigmaa, sigmab, gamma, c, sigmae) 
} 
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APPENDIX B 
This is the R code on real data (chapter 4) 
############################################################################# 
###########    Program One           ##################### 
###########  Plot survival and longitudinal data         ##################### 
############################################################################# 
 # Load packages JM,  lattice and lcmm   
# indicator for the composite event for the PBC dataset 
pbc2$status2 <- as.numeric(pbc2$status != "alive") 
pbc2.id$status2 <- as.numeric(pbc2.id$status != "alive") 
pbcSurv <- survfit(Surv(years, status2) ~  drug , data = pbc2.id) 
plot(pbcSurv, mark.time = FALSE, main = "Kaplan-Meier estimates of the probability of 
survival for the PBC data",  xlab = "Time", ylab = "Survivl Probability" , col = c("black", 
"red"), lty = 1:2) 
legend("topright", c("Placebo", "D-penicil"), lty = 1:2, col = c("black", "red"),bty = "n") 
xyplot(log(serBilir)~ year  | drug , group = id , data = pbc2, xlab = "Time", ylab = 
"log(Serbilir)", col = 1, type = "l", main = "Subject-specic evolutions in time of the Log of 
the Serbilir measurements, separately for Placebo and D-penicil.") 
 
######################################################################
###########   Program Two                    #################### 
###########  Fit Separate Model                      #################### 
###################################################################### 
 
 
sex_1 = factor(pbc2.id$sex, labels=c("male", "female"))
coxFit.pbc <- coxph(Surv(years, status2) ~ drug + log(age)+sex_1+serBilir, 
   data = pbc2.id, x = TRUE) 
baseline<-basehaz(coxFit.pbc)
summary(coxFit.pbc)
anova(coxFit.pbc) 
summary(baseline) 
 
 
###################################################################### 
###########   Program Three                    #################### 
###########  Fit Joint Model                             #################### 
###################################################################### 
sex_1 = factor(pbc2.id$sex, labels=c("male", "female"))
lmeFit.pbc <- lme(log(serBilir) ~ year, random = ~1+ year  | id, data = pbc2) 
coxFit.pbc <- coxph(Surv(years, status2) ~ drug + log(age)+sex_1, 
   data = pbc2.id, x = TRUE) 
jointFit <- jointModel(lmeFit.pbc, coxFit.pbc,  
 method = "piecewise-PH-aGH")
summary(jointFit) 
anova(jointFit) 
baseline<-basehaz(jointFit) 
summary(baseline) 
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APPENDIX C 
Table of real data (The first 20 Patient Observations)  
Case days Death Tx Age Sex Asc Hepa Spider Edema 
1 400 2 1 21464 1 1 1 1 1 
2 4500 0 1 20617 1 0 1 1 0 
3 1012 2 1 25594 0 0 0 0 0.5 
4 1925 2 1 19994 1 0 1 1 0.5 
5 1504 1 2 13918 1 0 1 1 0 
6 2503 2 2 24201 1 0 1 0 0 
7 1832 0 2 20284 1 0 1 0 0 
8 2466 2 2 19379 1 0 0 0 0 
9 2400 2 1 15526 1 0 0 1 0
10 51 2 2 25772 1 1 0 1 1 
11 3762 2 2 19619 1 0 1 1 0 
12 304 2 2 21600 1 0 0 1 0 
13 3577 0 2 16688 1 0 0 0 0 
14 1217 2 2 20535 0 1 1 0 1 
15 3584 2 1 23612 1 0 0 0 0
16 3672 0 2 14772 1 0 0 0 0 
17 769 2 2 19060 1 0 1 0 0 
18 131 2 1 19698 1 0 1 1 1 
19 4232 0 1 18102 1 0 1 0 0.5 
20 1356 2 2 21898 1 0 1 0 0 
Case Bili Chol Albu Urine Alka Sgot Tri Plate Proth Hist 
1 14.5 261 2.6 156 1718 137.95 172 190 12.2 4 
2 1.1 302 4.14 54 7394.8 113.52 88 221 10.6 3 
3 1.4 176 3.48 210 516 96.1 55 151 12 4 
4 1.8 244 2.54 64 6121.8 60.63 92 183 10.3 4 
5 3.4 279 3.53 143 671 113.15 72 136 10.9 3 
6 0.8 248 3.98 50 944 93 63 . 11 3 
7 1 322 4.09 52 824 60.45 213 204 9.7 3 
8 0.3 280 4 52 4651.2 28.38 189 373 11 3 
9 3.2 562 3.08 79 2276 144.15 88 251 11 2 
10 12.6 200 2.74 140 918 147.25 143 302 11.5 4 
11 1.4 259 4.16 46 1104 79.05 79 258 12 4 
12 3.6 236 3.52 94 591 82.15 95 71 13.6 4 
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13 0.7 281 3.85 40 1181 88.35 130 244 10.6 3 
14 0.8 . 2.27 43 728 71 . 156 11 4 
15 0.8 231 3.87 173 9009.8 127.71 96 295 11 3 
16 0.7 204 3.66 28 685 72.85 58 198 10.8 3 
17 2.7 274 3.15 159 1533 117.8 128 224 10.5 4 
18 11.4 178 2.8 588 961 280.55 200 283 12.4 4 
19 0.7 235 3.56 39 1881 93 123 209 11 3 
20 5.1 374 3.51 140 1919 122.45 135 322 13 4 
 
DATA:  Primary Biliary Cirrhosis (PBC) 
 
OBSERVATIONS: 418 
 
VARIABLES: 20 
 
VARIABLE DESCRIPTION: 
 
 
Case 
 Case number
 
Days 
 
The number of days between registration and the earlier of 
death, liver transplantation, or study analysis time in July, 1986.
 
Death 
 
2 = death 
1 = censored due to liver treatment
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Tx 
 
Treatment Code 
1 = D-penicillamine 
2 = placebo 
 
Age 
 
Age in years. For the first 312 cases, age was calculated by 
dividing the number of days between birth and study registration by 365. 
 
Sex 
 
0 = male 
1 = female 
 
Asc 
 
Presence of ascites
0 = no 
1 = yes 
 
Hepa 
 
Presence of hepatomegaly 
0 = no 
1 = yes 
 
Spider 
 
Presence of spiders  
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0 = no 
1 = Yes 
 
 
Edema 
 
Presence of edema
0 = no edema and no diuretic therapy for edema 
0.5 = edema present for which no diuretic therapy was given, or edema  
resolved with diuretic therapy 
1 = edema despite diuretic therapy 
 
Bili 
 
Serum bilirubin, in mg/dl 
 
Chol 
 
Serum cholesterol, in mg/dl 
 
Albu 
 
Albumin, in gm/dl 
 
Urine 
 
Urine copper, in mg/day 
 
Alka 
 
Alkaline phosphatase, in U/liter 
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Sgot 
 
SGOT, in U/ml 
 
Tri 
 
Triglycerides, in mg/dl 
 
Plate 
 
Platelet count; coded value is number of platelets per-cubic-milliliter of blood 
divided by 1000.
 
Proth 
 
Prothrombin time, in seconds 
 
Hist 
 
Histologic stage of disease, graded 1, 2, 3, or 4 
 
 
 
 
 
 
 
